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Abstract
Purpose – The purpose of this paper is to present the latest innovations in the drug distribution
processes of hospital companies, which are currently dealing with high inventory and storage costs
and fragmented organizational responsibilities.
Design/methodology/approach – The literature review and the in-depth analysis of a case
study support the understanding of the unit dose drug distribution system and the subsequent
definition of the practical implications for hospital companies.
Findings – Starting from the insights offered by the case study, the analysis shows that the unit
dose system allows hospitals to improve the patient care quality and reduce costs.
Research limitations/implications – The limitations of the research are those related to
the theoretical and exploratory nature of the study, but from a practical point of view, the work
provides important indications to the management of healthcare companies, which have to innovate
their drug distribution systems.
Originality/value – This paper analyzes a new and highly topical issue and provides several insights
for the competitive development of a fundamental sector.
Keywords Drug logistics innovation, Healthcare innovation, Healthcare supply chain management
Paper type Case study
Introduction
The supply chain (SC) is a process that includes all the activities from the identification
of a customer need through product selection, negotiation with suppliers, payment,
storage, distribution and redistribution (Colletti, 1994; Meijboom et al., 2010).
The supply chain management (SCM) therefore refers to upstream and downstream
relationships with suppliers and customers and to solving problems of functional
divisions that occur within and between organizations. Thus, there is a need for both
functional specialization as well as process orientation in organizations (Aronsson et al.,
2011). The philosophy of SCM is founded on collaboration among SC partners to
achieve greater benefits (Andraski, 1998; Stank et al., 2001). SCM was developed
initially in the context of manufacturing, but its introduction is beneficial to the
healthcare sector, where it shows an important impact on hospital performance,
in terms of reducing wastes, preventing medical errors, improving quality of care and
service and increasing operational efficiencies (Ford and Scanlon, 2006).
Healthcare SCM is different from SCM in other industries as it handles a diversity
of items in widely varying quantities in response to the large number of diagnosis types
and procedures (AbuKhousa et al., 2014). It includes the internal chain (patient care
units, hospital storage) and the external chain (producers, purchasers, distributors):
hospitals receive products and services from suppliers, and then store and distribute
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them to each care unit based on the hospital’s operation processes. Therefore,
healthcare SCM includes business activities and operations that integrate a continuous,
seamless flow of materials and services for healthcare delivery. It is designed to assure
a high service level by maximizing the resource allocation, in order to respond
effectively and promptly to the patient care needs and thus to achieve total quality
management. Its implementation has proven to be more complex than other
sectors, primarily because it requires the participation of many different stakeholders,
and also because it is highly influenced by legislations and by healthcare professionals
(Ford and Scanlon, 2006; Bhakoo and Chan, 2011; AbuKhousa et al., 2014).
Furthermore, healthcare is a customer-driven service, which means that customers are
an effective part of the process (Rossetti and Liu, 2009; Aronsson et al., 2011).
Healthcare SCM processes have three types of flows: product, information and financial
flows. The product flow or medical logistics at one hand includes the supply of
pharmaceutical, medical, surgical consumables, medical devices, hygiene consumables,
food supplies, equipment and other supplementary products necessaries to support
doctors, nurses and of course patients of hospitals. On the other hand, information and
financial flows are related to SC decisions for effective product flow and organizational
performance improvement (Lee et al., 2011; Shou, 2013).
The aim of this study is to investigate the emerging trends in pharmaceuticals
logistics flow redesign. Logistics and SC innovation are becoming a highly topical issue
in the international research agenda as well as in practice. The reason is that economic
and political factors have increased attention to healthcare issues, mainly because of
the rapid growth of healthcare costs: the aging of population, the increasing demand
for healthcare services, the rising cost of inpatient and outpatient care, professional
shortage, new technologies and new drugs will continue to drive up the total healthcare
cost. Currently, in the process of pharmaceutical products procurement, healthcare
companies accuse relevant gaps compared to other sectors, which can be partly
explained by the increased complexity that characterizes the logistics flow
management within sanitary companies: hospital companies tend to behave like
“individual agents” with their own purchasing offices, a pharmacy and an internal
distribution system based on order-delivery processes. Consequently, a large number
of transactions sent to different vendors and purchases of large quantities of drugs
from individual departments with consequent generation of inventory and storage
costs. As a natural consequence of this diversity of assets to manage, the organizational
responsibility of the logistics function is often fragmented and dispersed across
multiple organizational units, with clear coordination and integration problems.
It is clear that there are large areas of intervention in logistics, with possible
improvements in efficiency, quality and safety processes. The need for change the way
we manage healthcare facilities is due to some fundamental reasons: first, the
process of local health corporatization, which involves the introduction into the
national health system of control mechanisms, similar to the competitive market
models. Hospitals assume managerial and economic-financial autonomy, and they must
set their own goals for quality of service and cost management in order to ensure the
survival over time; second, limited resources and a steady growth in spending, hence,
the need of a public health rationalization, especially for meeting increasingly quality
demands. All this requires a profound transformation that affects not only the
processes of diagnosis and treatment, but also those of support, especially logistics,
which is essential for the processes of service differentiation and quality improvement
(Cagliano et al., 2007).
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In particular, the pharmaceutical logistics process assumes a central position in
ensuring the efficient healthcare operational functioning. Since it is crucial for hospital
operations, it requires an efficient internal organization; this is extremely difficult given
the complexity surrounding pharmaceutical healthcare system: a wide range of
products with completely different characteristics to manage, fragmented logistics
organizational responsibility, special kind of final customer and also the impact of
logistics in the quality of care provided to patients (Cagliano et al., 2007; Bensa et al.,
2009). Indeed, a fundamental measure of the quality of a drug distribution system is
the medication errors incidence, which is any discrepancy between the prescribed and
the administered medication (Kazemzadeh et al., 2012). The literature review and an
in-depth analysis of an Italian hospital company help us to explain how changes in
pharmaceutical logistics flow improve efficiency and reduce costs. Additionally,
the study extends to examine whether these efforts were successful and if so, how.
The paper is structured as follows: the next paragraph analyzes the drug logistics
process, followed by the study of drug logistics models adopted in healthcare settings;
then, the case study is presented; finally, the conclusion paragraph identifies the main
model limitations, the management implications and an indication of possible
developments for further research.
The pharmaceutical logistics process
Logistics management is the part of SCM that plans, implements and controls the
efficient and effective forward and reverse flow and storage of goods, services
and related information between the point of origin and the point of consumption in
order to meet customers’ requirements. Broadly speaking, logistics is concerned with
getting the right product (or service) to the right place at the right time. Logistics adds
value to products by creating utility, and the more the logistics contributes to the value
of a product, the more important the logistics management is. Place and time utilities
are directly affected by the logistics: place utility is the value added to a product by
making it available for purchase or consumption in the right place, while time utility is
the value added by making a product available at the right time. The essential
objectives of a good logistics include: first, improve management and staff performance
through a good leadership, training, supervision, clear expectation and working
conditions; second, improve information systems for accurate collects and reports data
when and where needed; third, improve forecasting/procurement; fourth, improve
distribution activities; fifth, clean, secure, organized storage; and finally, good transport
system (Chikumba, 2010). This is particularly vital in the domain of healthcare services,
where efficient provision of these services is expected from the general public.
The pharmaceutical logistics is the task of trying to place the right drugs and
medical supplies, in the right quantities, in the right conditions, at the right health
service delivery points, at the right time, for the right patients/users and for the right
cost (Chikumba, 2010). In particular, the logistics strict view (i.e. the micro-logistics)
considers a four-phase process: drug reception and warehouse/pharmacy operations,
request and validation, transportation, ward drug management. This process includes
all operations ranging from the drug prescription to drug administration, therefore
it involves two main components, therapy and inventory management, and two main
actors, wards and pharmacy (Cagliano et al., 2007; Bensa et al., 2009). These
key logistics steps are supported by a logistics management information system,
organizational effort (human resources, training, supervision, procedures and
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guidelines, equipment), financial resources (budgeting), political leadership (effective
policy and legal framework), evaluation and quality monitoring (products and work)
(Chikumba, 2010).
Managing healthcare logistics means to coordinate four basic elements:
(1) The operational model of service: it relates to operational decisions on various
aspects, from the wards deliveries frequency, to the stocks verification, to the
administration of stock goods.
(2) The organizational model: it refers to two dimensions of choice that determine
a significant impact on the overall logistics system: first, the level of logistics
functions centralization; second, the logistics cycle outsourcing degree.
(3) Technology and information system, capable of optimizing all stages of the
logistics.
(4) Lay-out and space organization: the warehouse organization, the lay-out
of corridors that connect the warehouse to the wards and the lay-out of patient
areas (Bensa et al., 2009) (Figure 1).
The increased complexity that characterizes the management of logistics flows within
the healthcare companies is linked to different aspects (Bensa et al., 2009):
(1) Healthcare companies manage at least three broad categories of goods
characterized by markedly different physical, logical and managerial
requirements: drugs, surgical medical products (medical devices and
healthcare material), economic goods. This creates also important problems
of space for the storage.
Source: Our adaptation from Bensa et al. (2009)
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Transportation
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Figure 1.
The healthcare
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(2) Logistics organizational responsibility is often fragmented and dispersed
among several organizational units with obvious problems of coordination
and integration. Multiple units have responsibility for the logistics in
healthcare organizations including: pharmacy, purchases, logistics,
information systems, wards.
(3) Healthcare companies treat people, and this introduces elements of natural
variability.
(4) Last but not less important point, logistics has an important impact on the
processes of care, that is on the quality and safety of care provided to patients.
In particular, when healthcare actors communicate and share information, they
are more likely to improve the quality in terms of patient safety, cycle time
reduction and operational efficiency (Carr and Pearson, 1999; Kotabe et al.,
2003; Prahinski and Benton, 2004; Giunipero et al., 2006; Carrus and Pinna,
2011). The safety of patients is the top priority in healthcare,
and pharmaceutical managers play a crucial role in protecting their interest.
The biggest responsibility of a pharmaceutical manager is to ensure that the
products purchased for clinical use are good quality ones. This can be achieved
by developing a product evaluation system consisting of well-defined
parameters to guarantee that only approved products can enter a hospital’s
stockroom. Additionally, the timely placement factor is probably not as crucial
in any other field as it is in healthcare delivery, where delay of a few seconds
can cost a life. Therefore, inventory managers have the huge responsibility of
making thousands of diverse medical consumables available on time.
Pharmaceutical logistics models
Managers and researchers are trying to improve cost cutting initiatives into the
healthcare operations management, where the single largest cost after labor is
materials. In fact, this sector is under increasing pressure in order to reduce wastes,
eliminate unnecessary costs while improving the quality and consistency of the patient
care. As the healthcare sector becomes increasingly complex, a key driver of cost and
quality is the pharmaceutical logistics process: the pharmaceutical management is
critical in ensuring high standards of patients care and providing adequate supplies
(Colletti, 1994; Ross and Jayaraman, 2009; Kazemzadeh et al., 2012; Smith et al., 2012).
Healthcare organizations should consider at least four dimensions of analysis to assess
the logistics system consequences: management costs; economic and financial benefits;
quality of service; safety. At the same cost a logistics system is better if it leads to
economic-financial savings and ensures the highest standards of quality and safety.
With regard to the measurable benefits, there are at least three areas of possible
recovery: first, the value of inventories; second, the value of ward stocks; and third,
the value of expired products. Among the quality standards concurrent multiple items
are significant, such as the response ability, the frequency of wards deliveries, the level
of goods traceability, etc. Security is certainly one of the dimensions of performance
that deserves more attention and that has strongly influenced decisions about the
logistics of healthcare companies in recent years. It is precisely in this area of activity
that the latest innovations in healthcare logistics are concentrated. Above all,
technological innovation in the near future will enable significant improvements
in efficiency, quality and safety in healthcare logistics, but it is necessary to emphasize
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that technology is only one component of a logistics system, and in order to achieve
the expected results, it must be consistent with the other components of the logistics
system and with the overall corporate strategic plan.
If it is clear what are the levers on which action is needed to change the logistics
system, it is less clear who should take responsibility for strategically and operationally
carry out the necessary change projects. This responsibility is actually fragmented
within different organizational units: the service of pharmacy; the office logistics;
purchases; information systems; the health wards; and the direction of nursing.
The trend seems to be the aggregation under a single organizational unit of all business
functions involved in the overall process of purchasing and logistics (Bensa et al., 2009).
According to the literature, there are currently three management models for drugs:
(1) The traditional managing: a central distribution source – pharmacy – in every
hospital decides what and how to buy according to requests, and delivers
medications to the wards, where it is available a standard stock of frequently
prescribed drugs. This is the most spread system and it entails the highest
inventory costs.
(2) The centralized managing: a unique district or regional center among multiple
hospitals recognizes the drugs needs, contacts the supplier and deals with
medication management.
(3) The logistics operator: all physical managing drugs movements are given to
a third partner who decide how and what to order in the hospital pharmacy.
The main problems related to the traditional system of drug management are related
to: the high value of wards fixed deposits; difficulties in controlling the drug
consumption at the ward level; the high risk of product obsolescence; the staff time
devoted to administrative and pharmaceuticals management; the wards stocks
location; unpredictability of requests for wards and the frequency of urgent requests;
the risk of failure in the early stages of patient care; preparation, administration and
the manual prescriptions transcription from paper medical records to the nursing
register paper. These problems create inefficiencies that result, directly or indirectly, in
a lower level of service and higher costs for the hospital (Cagliano et al., 2007). For this
reason, starting from the traditional healthcare logistics process, literature provides
interesting insights in favor of its redefinition. Among others, Chunning and Kumar
(2000) display the application of Just In Time (JIT) philosophy to the healthcare SCM.
Rivard-Royer et al. (2002) present the integration of the internal and external healthcare
SC with the hybrid stockless method. The healthcare SC business process
re-engineering proposed by Kumar et al. (2008) affects all components of the external
medical SC system. The virtually chain management with the creation of
a Consolidated Service Center is proposed from Parker and DeLay (2008). Finally,
Agwunobi and London (2009), take the cue from the mass retailer system, maintaining
a continuous focus on reducing costs. It is worth noting that the drug logistics systems
redefinition turn around the concepts of centralization of responsibilities pertaining to
the distribution in a single body among several hospitals and of the implementation
of stockless inventory methods. Indeed, one possible way to reduce costs of nonvalue-
added activities (procurement, storing and inventory management) in hospitals (as well
as in other organizations) is to develop partnerships with other entities that use
or provide those activities. The hospital may reduce costs by using the economies of
scale and/or obtaining new resources through partnerships. From here the definition of
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the other two innovative systems, the centralized managing and the logistics operator,
which include these innovative features. However, unlike what has happened
in manufacturing companies, in which logistics process is a strategic element of
management, the healthcare sector is still anchored, in most cases, to a traditional
system because they still hesitate to reduce the inventory level, due to higher lack
inventory costs compared to additional inventory ones. Nevertheless, current trends
and market pressure on the healthcare industry are making healthcare providers seek
ways to reduce operating costs (Aptel and Pourjalali, 2001; Cagliano et al., 2007).
These three management models are combined with innovative drug distribution
systems, which are not independent, but can be implemented in an integrated and
modular way, depending on various aspects such as the size of the hospital, its degree
of maturity towards the management of the drugs or their willingness to invest
(Aptel and Pourjalali, 2001; Cagliano et al., 2007; Kazemzadeh et al., 2012):
(1) Kanban carts system: a scheduling system for lean and JIT production
to control the logistical chain from a production point of view. It was developed
at Toyota to find a system for the improvement of a high level of production.
(2) Smart carts system: based on RFID, mobile and Wi-Fi technologies, it guides
nurses in the administration of drugs, reducing pharmaceutical expenditure
and eliminating the medication risk.
(3) Computerized prescription/case history system: it permits the centralization of
patient’s data collection (clinical history, tests and treatments in progress), their
electronic storage and elaboration, in order to help doctors making the best
decisions for patients care.
(4) Personalized unit dose system: a pharmacy-coordinated method of dispensing
and controlling medications in organized healthcare settings. It completely
changes the traditional process of inventory management, requiring that
medicines provided by suppliers to the hospital pharmacy in the
pharmaceutical packaging are divided into single-doses, using automatic
machines. These packs containing a single dose of drug, labeled with barcodes,
are stored in the warehouse locations and drawn on the basis of requests,
distributed with the manual or automatic dispenser (Cagliano et al., 2007).
The solution described may present some variations, depending on the specific
needs of the organization, but a number of distinctive elements are basic to all
unit dose systems (Kazemzadeh et al., 2012): first, medications are contained in
single unit packages; second, they are dispensed in as ready-to-administer form
as possible; third, for most medications, no more than a 24-hour supplier
is delivered to or available at the patient care area at any time. Literature
indicates that unit dose systems, with respect to other drug distribution
methods, are safer for the patient, more efficient and economical for the
organization, and it is a more effective method of utilizing professional
resources. More specifically, as the American Society of Hospital Pharmacy
(American Society of Health-System Pharmacists (ex American Society
of Hospital Pharmacy), 1993) point out, the most relevant advantages are the
following:
• a reduction in the incidence of medication errors;
• a decrease in the total cost of medication-related activities;
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• a more efficient usage of pharmacy and nursing personnel, allowing for
more direct patient care involvement by pharmacists and nurses;
• improved overall drug control and drug use monitoring;
• more accurate patient billings for drugs;
• the elimination or minimization of drug credits;
• greater control by the pharmacist over pharmacy workload patterns and
staff scheduling;
• a reduction in the size of drug inventories located in patient care areas; and
• greater adaptability to computerized and automated procedures.
In view of these demonstrated benefits, the American Society of Hospital Pharmacists
considers the unit dose system to be an essential part of drug distribution and control
systems in organized healthcare settings, in which drug therapy is an integral
component of the healthcare delivery. According to the literature, the strategies
adopted to reduce medication errors are essentially the following: first, computerized
recording of therapy; second, distribution of drugs in unit doses (with different levels
of automation); third, active participation of pharmacists in the management of
therapy. From an organizational point of view, it is necessary that the wards related to
materials, finance, receiving and store-keeping, work in tandem to process effectively
the high volume of purchases, receipt and payment transactions that take place at
regular intervals. The task of the purchase department is to procure the inventory
at lower prices without compromising the quality, by reducing the lead times with the
suppliers through competitive bidding, direct negotiation and group purchasing.
An efficient inventory policy should link the supply to the consumption patterns for
reducing the overall inventory level. Transactions should be online so that the database
gets updated automatically subsequently to each and every issue of material/medicine
in order to enhance efficiency (Kazemzadeh et al., 2012). The considerable benefits
provided by this innovative solution, as well as the significant changes that it requires,
lead us to explore this drug distribution method, addressing the analysis of a case
study, presented in the following section.
An Italian example of unit dose system implementation
Research methodology
Because the phenomenon studied here is complex and spread across multiple
organizations and in order to assess its peculiarities and criticalities, we chose a single
case study approach (Yin, 2014). As Rogers (1998) states: “data about the innovation
process are obtained by synthesizing the recallable perceptions of key actors in the
innovation process, written records of the organization adopting, and other sources”.
In Italy there are currently 11 active projects testing the unit dose drug distribution
system, involving a total number of approximately 10,000 beds and a total volume of
handled materials of about 460 million Euro. Among these projects, our case study deals
with the Hospital Company “G. Brotzu”, a higher example of elevated specialization in the
field of healthcare innovation. The case study methodology allowed us to combine
different data collection strategies, and, in particular, we analyzed official documentation,
regional laws, archives, historical data and organizational plans provided directly by the
organization, scientific journals, local newspapers and healthcare magazines.
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Background
The “G. Brotzu” hospital opened in Cagliari (Italian Region of Sardinia) in 1982, was
transformed into Autonomous Hospital Company by Legislative Decree 502/92, and
recognized as Hospital of National importance and high specialization with the Council
of Ministers President Decree 08.04.1993. The Company is part of the Regional Health
Service and, as part of the regional corporate governance, it is in charge of
high-performance specialization in some welfare activities at the national level.
It develops its activities through an open system, careful and sensitive to changes in the
general health demand and in the high-specialization sector in particular. With over
30,000 patients admitted annually in about 630 beds, the Company adopts the
Department as an organizational model aimed at ensuring the integration and shared
use of professional, logistics and technology resources of multiple related and/or
complementary structures that retain specific autonomy but are aggregated in terms of
organization and management, adopting a common code of conducting clinical care,
teaching and research. Specifically, the organizational departmental model, ensuring
the physical aggregation of multiple and functional structures, is configured as
a responsibility center of healthcare, administrative and financial management
activities. In this sense, within the Health Department, it is established the Hygiene and
Health Management Activities Department, which includes, among others,
the Complex Structure Pharmacy and Medicines Management. It is the health
support service of assistance activities, and it has the functions of planning,
coordinating and ensuring the pharmaceutical care and all the facilities of the company.
It has the responsibility of both clinical and managerial activities, including planning
and execution of medical devices and drugs procurement procedures, as well as
their procurement and use rationalization. Additionally, it makes prescription
pharmaceutical analysis about pertinence, guidelines and scientific evidence respect,
and finally, it is protagonist in the implementation of the drug distribution through the
latest technologies.
Discussion
The “project of pharmaceutical goods automation, unit dose drug implementation and
customized therapy for the traceability of medical devices”, started at the Brotzu
Hospital Company in 2002. The Company distributes the medication in unit dose for
personalized therapies at approximately 200 hospitalized patients, previously
with manual activities, then with special machinery ones. Needs analysis indicates
a quantity of unit doses of approximately 950,000 on an annual basis. The objectives
of the project are various, and they are classified in three categories: clinical, economic
and logistics, and administrative (Table I). The project aims a general re-engineering of
the drug prescription and administration processes, together with the realization of the
unit dose and the personalized and controlled therapy. Additionally, it seek to
implement a suitable system for the traceability of medical devices, in order to simplify
the loading and unloading processes both in the pharmacy and in the Company.
The following assumptions are considered essentials for the project:
(1) the total traceability of medicines requirements and administration;
(2) the unit dosage utilization for the largest possible number of pharmaceuticals;
(3) the support services implementation, quantitatively and qualitatively adapted
to the characteristics of innovation introduced by the supplies; and
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(4) the unique architecture of the project, able to express a coherent system
of technologies and services, integrated into the organizational and
informational aspects.
The project involves the replacement of technology currently present in the pharmacy
with a next-generation technology that enables greater efficiency, speed and safety in
the production of drugs in unit doses. The management model involves the use of ward
automated cabinets and centralized pharmacy for the personalized therapy
preparation. Automatic cabinets are located within some operational units identified
on the basis of logistics, economic and administrative considerations (presence
of appropriate spaces for the placement of the cabinet, the daily average consumption
of drugs, etc.); additional cabinets are placed in the pharmacy in order to assist the staff
dedicated to the preparation of therapies for wards missing the dedicated cabinet.
The project implementation is entrusted to an agency contract, but the hospital
pharmacy remains responsible about the packaging materials logistics (receipt,
storage, handling), together with the supervision, control, acceptance, validation and
use of all the activities made by the contractor. The unit dose drugs delivery to wards is
required at the contractor’s personnel, while the hospital staff remains in charge of their
administration once delivered (in particular storage operations within technologies).
Before the implementation
Traditionally, the pharmaceutical flow within the hospital involves different actors
operating in different sectors which play a number of activities interacting with each
other (Figure 2).
The process starts with the doctor therapy prescription (type of drug, dose and time
of administration) to be administered to the patient (Phase 1). This prescription is then
manually transmitted to nurses who then write it down on the nursing register.
The head nurses (or the nurses) consult the patient register and check the ward cart for
Clinical objectives
Economic and
logistics objectives Administrative objectives
Reduce errors of transcription and
interpretation
Optimization of
pharmaceutical
expenditure
Quantification of pharmaceutical
expenditure
Greater control on therapeutic profiles
and drugs appropriateness
Reduction of ward and
department
inventories
Computerized management of
stocks, even at the departmental
level
Decision support to the prescription Reduction/elimination
of expired drugs
Consumption monitoring
Medication errors and related adverse
events reduction
Drugs traceability
Simplification of management
procedures
Prescriptions and therapies monitoring
and traceability
Ability to integrate data related to
treatment within the medical record
Medical devices
traceability
Optimization of human resources
commitment (in particular the recovery of
nursing time)
Logistics optimization
Source: Our elaboration
Table I.
Unit dose
implementation
project objectives
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the presence of drugs needed for the next round of administration. In case of medicines
missing, they recuperate them in the ward warehouse. The ward cart replenishment
can be done simultaneously with the prescription or at the end of the administration
round. Once each patient is identified, visually and by looking at the number of
room/bed and name, nurses consult its treatment in the nursing register and identifies
the drug by reading the name on the package. If the medicine is not present on the
basket, they provide for recovering it. The administration and its outcome are finally
written down on paper (Phases 2 and 3).
With frequency varying from department to department (from once a day to once a
week) and independently by prescription/administration, the head nurses or
administrative personnel control the quantity of drugs in the ward warehouse to
determine the volumes to be taken to the pharmacy. This is one of the most important
phases of the drug logistics process. However, in this phase special techniques are
not used because each operator usually relies on his knowledge and experience.
Always with variable frequency, nurses carry out the inventory of materials in the ward
warehouse and in the ward cart: counting, sorting, packaging, elimination of any overdue
materials. This operation is usually carried out during the night shift (Phase 4). The needs
analysis output is the list of items to be requested: for encoded material already present at
the central warehouse, the employee makes a withdrawal request for the required amount;
for new material not found in the register, a purchase request is made with an extended
PHASE DOCTORS HEADNURSE NURSES
PHARMACY
MANAGER
PHARMACY
STAFF
1 Definition of thetherapy
2 Cart preparation
3
Preparation and administration
of drugs prescribed to patients
by nurses
4 Analysis of the department
needs
5 Withdrawal or purchase requestat the pharmacy
6
Analyze requests and
authorizes companies
to engage in picking
7
      Check for
the presence of
codes and
wondered if
any of expired
drugs
8
Preparation of
carts with items
ordered from
departments
9
Verification of the
correctness and
signing the bill of
delivery
10
Transport of
carts to the
wards
Source: Our elaboration
Figure 2.
The traditional
pharmaceutical flow
at Brotzu hospital
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item description containing detailed technical characteristics. Both requests are mostly
drawn on paper and transferred to the pharmacy directly or by computer (Phase 5).
At this point, the pharmacist analyzes requests and authorizes operators to perform
the picking (Phase 6), and the warehouse personnel verify the presence of wondered
codes and expired medicines (Phase 7). Drug packages are then collected from the
pharmacy according to the picking lists, and ward carts are set up with items ordered
from each department (Phase 8). Next, the unloading amount of drugs is needed:
the material is downloaded from the central warehouse and simultaneously uploaded to
the periphery one. At the end of collection procedures, the pharmacist verifies the
correctness and sign the bill of delivery (Phase 9). Finally, warehouse or department
personnel transports carts with boxes of medicines to destination wards (Phase 10).
Periodically, based on sampling, measurement units and class value of items
in central warehouse, the pharmacy performs a consumption analysis by updating the
parameters of the minimum stock. The comparison of these parameters with
the inventoried material in stock identifies the under-provisions that must be ordered
to suppliers. If an ordered material is in late delivery, the pharmacy issues a reminder to
the supplier. This procurement procedure through the central pharmacy is sometimes
used only for ordinary products, namely those of wide use and economic value content.
The so-called “special products”, rarely used and often of high value, can be ordered
directly from suppliers departments. In this situation, the pharmacy is responsible only
for their transfer. Once drugs arrive in the ward, the head nurse signs for acceptance
on the bill of delivery, and then proceed to their storage. The drug packs order criteria
are completely discretionary and may vary from department to department, for
example, the alphabetical order with the growing expiry date.
The process just described allows us to highlight some critical aspects of the traditional
system of pharmaceutical management (see list below). In particular, it is emphasized that
the stocks held in the central and ward stores are too large compared to those needed to
prevent stock breakages. This practice creates inefficiencies that result, directly
or indirectly, in a lower level of service and higher costs for the hospital. Unfortunately,
very often those involved in the management of the warehouses are not aware of the
economic performance of the structure. Another aspect worthy of consideration is the
excessive involvement of nurses in activities not related to their profession: the inventory
control department, the preparation of requests to the pharmacy, the transport of material
from the warehouse to the department and its storage. All this reduces the time available
for the treatment and care of patients and adversely affect the level of nursing service.
Traditional distribution system criticalities (Source: Our adaptation from Cagliano
et al., 2007):
Criticalities
(1) High value of ward fixed deposits.
(2) Failure to check the actual ward consumption.
(3) Lack of methodologies and tools available to the hospital staff for the ward
consumption estimation (management of orders is based on experience).
(4) High risk of product obsolescence (managing deadlines is difficult).
(5) High time spent by administrative and healthcare staff for pharmaceutical
management (requirements analysis, receipt and storage, management of
packaging and packaging needs of frequent inventories, etc.).
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(6) Location of ward stocks (often do not directly feeds a shelf, but it is left to
the nurse, within a box, the set of requests processed. Even in cases where there
is a shelf, the criteria for his coverage are discretionary).
(7) Unpredictability of requests for wards.
(8) High frequency of urgent requests.
(9) Risk of error in the early stages of association and patient care, preparation and
administration of the drug (all controls are visual and left to nurses).
(10) Manual transcription of prescriptions from paper medical records to the
nursing register paper (loss of information risk).
After the implementation
The unit dose system adoption at the Brotzu Hospital (Figure 3) required particularly
significant organizational changes with regard to the physical and informative flows
management.
The doctor, during the tour visit, take notes on paper, then he goes to a ward
terminal and personally types the demand for care, which is performed on the active
principle (Phase 1). After the acceptance, drugs are delivered to the pharmacy (Phase 2):
here, two-dimensional barcodes are printed, placed on sacks of unit doses, on products
that have a not legible commercial code or on individual doses that do not have the
commercial code on the individual blister (Phase 3). After the cart preparation (Phase 4),
a general check and the signature by the pharmacy manager take place (Phase 5).
Unit doses are than delivered to the wards semi-automatic dispenser cabinets with
drawers, containing 24 hours of spare (Phase 6). Each nurse is dedicated to three to five
patients and to read doctor’s prescription they are equipped with: a laptop and a
barcodes reader, connected in a wireless network; a personal ward trolley, equipped
PHASE DOCTORS HEADNURSE NURSES
PHARMACY
MANAGER
PHARMACY
STAFF
1 Computerized prescription
2 Reception and control
of therapies
3
Unit dose and
personalized
therapies
preparation
4 Cart preparation
5 Checking and signing
6
Computerized cabinet:
reception of the box with
therapy for 24 hours
divided by sectors
7
Therapy administered to
the patient through the use
of barcode
Source: Our elaboration
Figure 3.
The unit dose flow
at Brotzu hospital
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with a personal computer through which they read dosing and print labels. Then,
to access the dispenser, nurses insert the personal code and retrieve products from
specific drawers that open automatically. Drugs prescribed to patient with bracelet are
then administered and automatically downloaded from the inventory (Phase 7).
The project required structural and plant design work for the system functionality
(wireless network, machineries installation, etc.), the purchase of equipment for
automatic dispensing, the hardware (tablets and palmtops for administration control)
and software (prescription program, administration, warehouse), as well as for patient
identification bracelets with printing serialized barcodes. Briefly, the drugs
administration is now regulated by a computerized system that collects the
therapeutic prescriptions, written by the physician for each patient through
the tablet linked to the network with the pharmacy. In the pharmacy, machinery
provides for the automatic packaging of medications in single-doses and for the
composition of rings containing the personalized therapy of the patient, labeling the
box with patient vital statistics and time of administration, and reporting data to a
barcode. Finally, packages are sent to the ward on a daily basis and for a period of
24-hour coverage. Here, before proceeding to the administration, nursing staff
cross-check therapy, patient, administration time, personnel carrying out the
administration. The patient identification is carry out by reading the barcode
bracelet and noting the coincidence of the data indicated on the package containing the
personalized therapy, thanks to a palmtop reader with infrared, connected to the
hospital network.
This system has allowed the Brotzu Hospital to obtain considerable advantages
in terms of:
(1) ward stocks reductions;
(2) reduced inventory of the pharmacy warehouse;
(3) a reduction of medicines cabinet management;
(4) a reduction in the likelihood of errors; and
(5) a simplification of the overall process of ward carts preparation and
medicines administration.
Conclusions and directions for future research
The present work aimed to investigate the emerging trends in the pharmaceuticals
logistics flow redesign by focussing on the unit dose distribution system. We presented
an Italian case study to explain how this innovative method improve efficiency and
reduce costs. The hospitals corporatization process focusses the attention on the
efficient use of resources, the need to reconfigure the healthcare logistics and,
in particular, the pharmaceuticals management, whose importance is fundamental to
the provision of care services to patients.
While the manufacturing sector has always been at the forefront of experimental
approaches to rationalize inventory and material flow, the healthcare sector has long
remained anchored to traditional approaches based on maintaining high quantities
of products in stock to avoid the risk of stock out, and in poorly formalized and
automated stages. Although nowadays many hospitals continue to adopt this scheme
for the drug flow management, some are actually applying industrial principles, first of
all those relating to the JIT philosophy, in order to overcome the limitations of such an
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approach. Assessing the state of the art in Italy and abroad, there appear some
innovative systems: from Kanban carts to intelligent carts, until the personalized
and unit dose system. The hospitals logistics re-engineering development will be
increasingly based on the integrated implementation of these solutions, depending on
various aspects, such as the size of the hospital, its degree of maturity towards the drug
management or their willingness to invest.
Among these innovative ways of managing drugs, the case study we have
presented analyzes a unit dose distribution system implementation. This system
requires that medicines are divided into single-patient-personalized doses, with a
significant elimination or minimization of drug inventories and a reduction in
the incidence of medication errors. In particular, this work has identified some
progressive levels of logistic redefinition: from the use of automated carts shelves to
supply wards, up to the realization of an effective flow where the request to the central
pharmacy is directly derived from the requirements and no longer by subjective
assessments of head nurses. Each of these stages is supported by an increasing level of
automation and computerization. The jointly application of different tools for
the pharmaceutical flows optimization allows hospitals to create synergies between its
benefits and overcome their weaknesses, achieving cost reductions and increased
patient care quality. The work, far from being definitive, represents a first attempt to
explore this highly topical issue; it is therefore desirable that future research destinies
more and more attention to it, focussing on the latest possibilities offered by the
Information and Communication Technology in favor of patient quality care.
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